Effect of daclizumab (Zenapax) on prevention of acute rejection of renal transplantation

By Poorrezagholi F.   Einollahi B.   Firoozan A.   Nafar M.   Yadegari H.   Moghaddam S.M.M.H.   Simforoosh N.   Basiri A.   Farhangi S.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2735-2736

Elsevier

Access to resources Recommend Favorite

Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation

By Ekberg H.   Backman L.   Tufveson G.   Tyden G.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 267-268

Elsevier

Access to resources Recommend Favorite

Placebo-Controlled Study of a Humanized Anti-TAC Monoclonal Antibody in Dual Therapy for Prevention of Acute Rejection After Renal Transplantation

By Charpentier B.   Thervet E.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1331-1332

Elsevier

Access to resources Recommend Favorite

Effect of deoxyspergualin on acute and chronic rejection in renal transplantation

By Nomura Y.   Tomikawa S.   Beck Y.   Nishimura Y.   Meigata K.   Ando Y.   Kikuchi K.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3580-3581

Elsevier

Access to resources Recommend Favorite

Plasmapheresis for the Treatment of Acute Vascular Rejection in Renal Transplantation

By Aichberger C.   Nussbaumer W.   Rosmanith P.   Riedmann B.   Spechtenhauser B.   Feichtinger H.   Fend F.   Pernthaler H.   Ofner D.   Schonitzer D.   Margreiter R.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 169-170

Elsevier

Access to resources Recommend Favorite